{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:35:36Z","timestamp":1788950136895,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-LABX-53-01"],"award-info":[{"award-number":["ANR-10-LABX-53-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009469","name":"R\u00e9gion Centre-Val de Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.mucimm.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T12:04:58Z","timestamp":1680005098000},"page":"312-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-019X","authenticated-orcid":false,"given":"Aubin","family":"Pitiot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Boisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bouvart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-5068","authenticated-orcid":false,"given":"Nathalie","family":"Heuz\u00e9-Vourc'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"S\u00e9cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2023.03.005_b0005","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3389\/fimmu.2019.02760","article-title":"Inhalation of immuno-therapeutics\/-prophylactics to fight respiratory tract infections: an appropriate drug at the right place","volume":"10","author":"Secher","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2018.05.003","article-title":"Therapeutic antibodies: a new era in the treatment of respiratory diseases?","volume":"189","author":"Secher","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mucimm.2023.03.005_b0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2326-6066.CIR-15-0120","article-title":"Fc-receptor interactions regulate both cytotoxic and immunomodulatory therapeutic antibody effector functions","volume":"3","author":"DiLillo","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mucimm.2023.03.005_b0020","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/annonc\/mdh472","article-title":"Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity","volume":"15","author":"de Bono","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0025","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-07-0507","article-title":"Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy","volume":"13","author":"Taylor","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mucimm.2023.03.005_b0030","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood-2004-03-1110","article-title":"From the bench to the bedside: ways to improve rituximab efficacy","volume":"104","author":"Cartron","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mucimm.2023.03.005_b0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM199210223271705","article-title":"Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors","volume":"327","author":"Kwak","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0040","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2008-10-185280","article-title":"Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a \u201cvaccinal effect\u201d of rituximab","volume":"113","author":"Hilchey","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mucimm.2023.03.005_b0045","doi-asserted-by":"crossref","first-page":"10569","DOI":"10.1128\/JVI.01503-14","article-title":"Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB\/c mice","volume":"88","author":"Boyoglu-Barnum","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2023.03.005_b0055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential Fc-receptor engagement drives an anti-tumor vaccinal effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2023.03.005_b0060","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2012-06-432153","article-title":"Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies","volume":"121","author":"Nasser","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.mucimm.2023.03.005_b0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/icb.2014.26","article-title":"OX40 engagement depletes intratumoral Tregs via activating FcgammaRs, leading to antitumor efficacy","volume":"92","author":"Bulliard","year":"2014","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.mucimm.2023.03.005_b0070","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2009-10-248609","article-title":"Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response","volume":"116","author":"Abes","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mucimm.2023.03.005_b0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COH.0000000000000555","article-title":"Vaccinal effect of HIV-1 antibody therapy","volume":"14","author":"Naranjo-Gomez","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.mucimm.2023.03.005_b0080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tim.2015.07.005","article-title":"Antiviral monoclonal antibodies: can they be more than simple neutralizing agents?","volume":"23","author":"Pelegrin","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0085","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall'Acqua","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mucimm.2023.03.005_b0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","article-title":"Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys","volume":"108","author":"Hart","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2016.05.018","article-title":"Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin","volume":"234","author":"Respaud","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mucimm.2023.03.005_b0100","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/AAC.00290-15","article-title":"Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies","volume":"59","author":"Leyva-Grado","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mucimm.2023.03.005_b0105","article-title":"Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters","volume":"2","author":"Piepenbrink","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2019.04.005","article-title":"In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration","volume":"303","author":"Secher","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mucimm.2023.03.005_b0115","doi-asserted-by":"crossref","first-page":"e00052","DOI":"10.1128\/JVI.00052-20","article-title":"Airway delivery of anti-influenza monoclonal antibodies results in enhanced antiviral activities and enables broad-coverage combination therapies","volume":"94","author":"Vigil","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0125","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/JVI.00207-09","article-title":"Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge","volume":"83","author":"Perrone","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0130","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-018-0095-z","article-title":"From therapeutic antibodies to immune complex vaccines","volume":"4","author":"Wang","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.mucimm.2023.03.005_b0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/icb.1995.65","article-title":"Pulmonary immunity to Pseudomonas aeruginosa","volume":"73","author":"Cripps","year":"1995","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000455857","article-title":"Inflammation: a double-edged sword in the response to Pseudomonas aeruginosa infection","volume":"9","author":"Lin","year":"2017","journal-title":"J. Innate Immunity"},{"key":"10.1016\/j.mucimm.2023.03.005_b0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2249.2002.01974.x","article-title":"Humoral immunity and bronchiectasis","volume":"130","author":"Stead","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcimb.2016.00170","article-title":"IL17-Producing gammadelta T cells may enhance humoral immunity during pulmonary Pseudomonas aeruginosa infection in mice","volume":"6","author":"Pan","year":"2016","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0160","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.20031498","article-title":"Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen","volume":"198","author":"Song","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.molimm.2004.06.041","article-title":"The BAFF\/APRIL system: life beyond B lymphocytes","volume":"42","author":"Ng","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0170","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.vaccine.2007.12.007","article-title":"Vaccines and immunotherapy against Pseudomonas aeruginosa","volume":"26","author":"Doring","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2023.03.005_b0175","first-page":"938","article-title":"Antibiotic resistance threats in the United States: stepping back from the brink","volume":"89","author":"Solomon","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.mucimm.2023.03.005_b0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1089\/mdr.2018.0266","article-title":"Molecular epidemiology of endemic carbapenem-resistant gram-negative bacteria in an intensive care unit","volume":"25","author":"Karampatakis","year":"2019","journal-title":"Microb. Drug Resis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhin.2018.05.010","article-title":"Impact of active surveillance and infection control measures on carbapenem-resistant gram-negative bacterial colonization and infections in intensive care","volume":"99","author":"Karampatakis","year":"2018","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.mucimm.2023.03.005_b0190","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-018-3244-4","article-title":"Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data","volume":"37","author":"Karampatakis","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.mucimm.2023.03.005_b0200","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/514760","article-title":"Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa","volume":"28","author":"Harris","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MCP.0b013e32835f1afc","article-title":"Respiratory bacterial infections in cystic fibrosis","volume":"19","author":"Ciofu","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1513\/AnnalsATS.201310-350OC","article-title":"Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease","volume":"11","author":"Desai","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.mucimm.2023.03.005_b0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"Wilson","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0220","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.chest.2018.12.008","article-title":"Epidemiology and predictors of 30-day readmission in patients with sepsis","volume":"155","author":"Gadre","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.mucimm.2023.03.005_b0225","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s11095-011-0442-5","article-title":"The airways, a novel route for delivering monoclonal antibodies to treat lung tumors","volume":"28","author":"Maillet","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mucimm.2023.03.005_b0230","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1517\/17425247.2015.999039","article-title":"Nebulization as a delivery method for mAbs in respiratory diseases","volume":"12","author":"Respaud","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.mucimm.2023.03.005_b0235","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2014.10.003","article-title":"Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system","volume":"196","author":"Guilleminault","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mucimm.2023.03.005_b0240","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/CVI.00002-10","article-title":"Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice","volume":"17","author":"Ye","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0245","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20020338","article-title":"Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells","volume":"195","author":"Kalergis","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0250","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0255","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI0215640","article-title":"Immune complex-mediated antigen presentation induces tumor immunity","volume":"110","author":"Rafiq","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mucimm.2023.03.005_b0265","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fimmu.2014.00140","article-title":"Antigen cross-presentation of immune complexes","volume":"5","author":"Platzer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0270","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1038\/emi.2016.97","article-title":"Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play","volume":"5","author":"Lambour","year":"2016","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.mucimm.2023.03.005_b0275","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.15252\/emmm.201606593","article-title":"Immunoregulatory functions of immune complexes in vaccine and therapy","volume":"8","author":"Wen","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0280","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41591-018-0001-2","article-title":"A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection","volume":"24","author":"Gautam","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0285","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.97.3.431","article-title":"A factor in the serum of patients with persisting infection that inhibits the bactericidal activity of normal serum against the organism that is causing the infection","volume":"97","author":"Waisbren","year":"1966","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0290","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","article-title":"Mechanism and regulation of immunoglobulin isotype switching","volume":"54","author":"Coffman","year":"1993","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0295","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.4049\/jimmunol.1401031","article-title":"Dissecting the contribution of IgG subclasses in restricting airway infection with Legionella pneumophila","volume":"193","author":"Weber","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0300","doi-asserted-by":"crossref","first-page":"e02059","DOI":"10.1128\/mBio.02059-20","article-title":"The role of IgG subclass in antibody-mediated protection against carbapenem-resistant Klebsiella pneumoniae","volume":"11","author":"Motley","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.mucimm.2023.03.005_b0305","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4049\/jimmunol.46.5.319","article-title":"The complementary activity of mouse-serum","volume":"46","author":"Brown","year":"1943","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0310","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.119.3103.877.a","article-title":"Lack of bactericidal effect of mouse serum on a number of common microorganisms","volume":"119","author":"Marcus","year":"1954","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2023.03.005_b0315","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1000284","article-title":"Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody","volume":"186","author":"Siggins","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","article-title":"The establishment of resident memory B cells in the lung requires local antigen encounter","volume":"20","author":"Allie","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0325","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20090410","article-title":"Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice","volume":"206","author":"GeurtsvanKessel","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0330","doi-asserted-by":"crossref","first-page":"e141810","DOI":"10.1172\/JCI141810","article-title":"Lung-resident memory B cells protect against bacterial pneumonia","volume":"131","author":"Barker","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mucimm.2023.03.005_b0335","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/JVI.79.10.6272-6280.2005","article-title":"Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment","volume":"79","author":"Gros","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0340","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1128\/JVI.00568-10","article-title":"Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody","volume":"84","author":"Nasser","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0345","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2011.07.011","article-title":"Innate immune responses to Pseudomonas aeruginosa infection","volume":"13","author":"Lavoie","year":"2011","journal-title":"Microbes. Infect."},{"key":"10.1016\/j.mucimm.2023.03.005_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.625597","article-title":"Immune responses to Pseudomonas aeruginosa biofilm infections","volume":"12","author":"Moser","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0355","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/2049-632X.12043","article-title":"The responses of gammadelta T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17","volume":"68","author":"Liu","year":"2013","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/infdis\/jis657","article-title":"Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia","volume":"207","author":"Kamei","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0365","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-gamma from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection","volume":"190","author":"Green","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0370","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biocel.2014.01.013","article-title":"Phagocytic and signaling innate immune receptors: are they dysregulated in cystic fibrosis in the fight against Pseudomonas aeruginosa?","volume":"52","author":"Sallenave","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mucimm.2023.03.005_b0375","doi-asserted-by":"crossref","first-page":"e00451","DOI":"10.1128\/IAI.00451-20","article-title":"Defining the mechanistic correlates of protection conferred by whole-cell vaccination against Pseudomonas aeruginosa acute murine pneumonia","volume":"89","author":"Sen-Kilic","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0380","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1128\/IAI.68.8.4585-4592.2000","article-title":"Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa","volume":"68","author":"Cheung","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0385","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/IAI.66.7.3164-3169.1998","article-title":"Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia","volume":"66","author":"Kooguchi","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0390","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1128\/IAI.00927-08","article-title":"Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa","volume":"77","author":"Tertilt","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0395","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/593186","article-title":"Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease","volume":"47","author":"Martinez-Solano","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0400","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","article-title":"Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations","volume":"57","author":"Patel","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.mucimm.2023.03.005_b0405","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mucimm.2023.03.005_b0410","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.66.8.3719-3726.1998","article-title":"Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains","volume":"66","author":"Hatano","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0415","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/infdis\/174.3.537","article-title":"Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group","volume":"174","author":"Donta","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0420","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.71.3.1453-1461.2003","article-title":"Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant","volume":"71","author":"Priebe","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0425","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2023.03.005_b0430","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2011.10.018","article-title":"Th17 cells mediate clade-specific, serotype-independent mucosal immunity","volume":"35","author":"Chen","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.mucimm.2023.03.005_b0435","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jiz692","article-title":"Trained immunity confers broad-spectrum protection against bacterial infections","volume":"222","author":"Ciarlo","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2023.03.005_b0440","volume":"24","author":"Roberts","year":"2021","journal-title":"Pulmonary infection induces persistent, pathogen-specific lipidomic changes influencing trained immunity."},{"key":"10.1016\/j.mucimm.2023.03.005_b0445","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cell.2018.11.007","article-title":"Trained immunity and local innate immune memory in the lung","volume":"175","author":"Netea","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2023.03.005_b0450","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1084\/jem.20132444","article-title":"Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing","volume":"211","author":"Wells","year":"2014","journal-title":"J. Exp. Med."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021923000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021923000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:31:58Z","timestamp":1761831118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021923000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1933021923000211"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2023.03.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.04.498699","asserted-by":"object"}]},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}